We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Devicemakers Question Value of CMS, FDA Parallel Review
Devicemakers Question Value of CMS, FDA Parallel Review
December 30, 2010
Despite claims by the FDA and Centers for Medicare & Medicaid Services (CMS) that parallel review could expedite marketing of new devices, industry fears the opposite could happen, depending on how the program is implemented.